Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2012

01-01-2012 | Otology

Inhibition of fibroblast growth factor receptor 1: influence on tympanic membrane wound healing in rats

Authors: Holger Kaftan, Lars Reuther, Bärbel Miehe, Werner Hosemann, Achim Beule

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2012

Login to get access

Abstract

An animal model of chronic tympanic membrane (TM) perforation is needed for experiments on supporting healing of TM perforations. The basic fibroblast growth factor is important in TM wound healing. The object of this study was to investigate the efficacy of fibroblast growth factor receptor 1 (FGFR1) inhibition to arrest wound healing of experimental TM perforation. Bilateral instrumental myringotomies were performed in 12 rats. A specific inhibitor of the FGFR1 tyrosine kinase (SU5402) was applied to the left TM (2 mg/ml) and to the right TM (10 mg/ml) of each animal daily for 12 consecutive days. Thereafter, TMs were observed weekly for a total of 30 days. TM healing was delayed in a dose-dependent manner. We observed differences in the histologic parameters between both groups. SU 5402 is a strong inhibitor of TM healing but seems not to be suitable to create a chronic TM perforation in rat.
Literature
1.
go back to reference Hakuba N, Iwanaga M, Tanaka S, Hiratsuka Y, Kumabe Y, Konishi M, Okanoue Y, Hiwatashi N, Wada T (2010) Basic fibroblast growth factor combined with atelocollagen for closing chronic tympanic membrane perforations in 87 patients. Otol Neurotol 31:118–121PubMedCrossRef Hakuba N, Iwanaga M, Tanaka S, Hiratsuka Y, Kumabe Y, Konishi M, Okanoue Y, Hiwatashi N, Wada T (2010) Basic fibroblast growth factor combined with atelocollagen for closing chronic tympanic membrane perforations in 87 patients. Otol Neurotol 31:118–121PubMedCrossRef
2.
go back to reference Kaftan H, Eyrich D, Schindler E, Göpferich A, Hosemann W (2006) Fibrin gel for treatment of tympanic membrane perforations: an experimental animal model. HNO 54:943–946PubMedCrossRef Kaftan H, Eyrich D, Schindler E, Göpferich A, Hosemann W (2006) Fibrin gel for treatment of tympanic membrane perforations: an experimental animal model. HNO 54:943–946PubMedCrossRef
3.
go back to reference Boedts D, Ars B (1977) Histopathological research on eardrum perforations. Arch Otorhinolaryngol 215:55–59PubMedCrossRef Boedts D, Ars B (1977) Histopathological research on eardrum perforations. Arch Otorhinolaryngol 215:55–59PubMedCrossRef
4.
go back to reference Kaftan H, Hosemann W, Beule A, Junghans D (2004) An improved animal model for chronic perforation of the tympanic membrane. HNO 52:714–719PubMed Kaftan H, Hosemann W, Beule A, Junghans D (2004) An improved animal model for chronic perforation of the tympanic membrane. HNO 52:714–719PubMed
5.
go back to reference Mondain M, Ryan A (1995) Epidermal growth factor and basic fibroblast growth factor are induced in guinea-pig tympanic membrane following traumatic perforation. Acta Otolaryngol (Stockh) 115:50–54CrossRef Mondain M, Ryan A (1995) Epidermal growth factor and basic fibroblast growth factor are induced in guinea-pig tympanic membrane following traumatic perforation. Acta Otolaryngol (Stockh) 115:50–54CrossRef
6.
go back to reference Mondain M, Ryan A (1993) Histological study of the healing of traumatic tympanic membrane perforation after basic fibroblast growth factor application. Laryngoscope 103:312–318PubMedCrossRef Mondain M, Ryan A (1993) Histological study of the healing of traumatic tympanic membrane perforation after basic fibroblast growth factor application. Laryngoscope 103:312–318PubMedCrossRef
7.
go back to reference Chellaiah A, Yuan W, Chellaiah M, Ornitz DM (1999) Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem 274:34785–34794PubMedCrossRef Chellaiah A, Yuan W, Chellaiah M, Ornitz DM (1999) Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem 274:34785–34794PubMedCrossRef
8.
go back to reference Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139–149PubMedCrossRef Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139–149PubMedCrossRef
9.
go back to reference Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J (1997) Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276:955–960PubMedCrossRef Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J (1997) Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276:955–960PubMedCrossRef
10.
go back to reference Bernard-Pierrot I, Ricol D, Cassidy A, Graham A, Elvin P, Caillault A, Lair S, Broët P, Thiery JP, Radvanyi F (2004) Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor. Oncogene 23:9201–9211PubMed Bernard-Pierrot I, Ricol D, Cassidy A, Graham A, Elvin P, Caillault A, Lair S, Broët P, Thiery JP, Radvanyi F (2004) Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor. Oncogene 23:9201–9211PubMed
11.
go back to reference Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J (2005) Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11:2702–2712PubMedCrossRef Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J (2005) Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11:2702–2712PubMedCrossRef
12.
go back to reference Redmond SL, Levin B, Heel KA, Atlas MD, Marano RJ (2011) Phenotypic and genotypic profile of human tympanic membrane derived cultured cells. J Mol Hist 42:15–25CrossRef Redmond SL, Levin B, Heel KA, Atlas MD, Marano RJ (2011) Phenotypic and genotypic profile of human tympanic membrane derived cultured cells. J Mol Hist 42:15–25CrossRef
13.
go back to reference Fischer H, Taylor N, Allerstorfer S, Grusch M, Sonvilla G, Holzmann K, Setinek U, Elbling L, Cantonati H, Grasl-Kraupp B, Gauglhofer C, Marian B, Micksche M, Berger W (2008) Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Mol Cancer Ther 7:3408–3419PubMedCrossRef Fischer H, Taylor N, Allerstorfer S, Grusch M, Sonvilla G, Holzmann K, Setinek U, Elbling L, Cantonati H, Grasl-Kraupp B, Gauglhofer C, Marian B, Micksche M, Berger W (2008) Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Mol Cancer Ther 7:3408–3419PubMedCrossRef
14.
go back to reference Widberg CH, Newell FS, Bachmann AW, Ramnoruth SN, Spelta MC, Whitehead JP, Hutley LJ, Prins JB (2009) Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am J Physiol Endocrinol Metab 296:E121–E131PubMedCrossRef Widberg CH, Newell FS, Bachmann AW, Ramnoruth SN, Spelta MC, Whitehead JP, Hutley LJ, Prins JB (2009) Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am J Physiol Endocrinol Metab 296:E121–E131PubMedCrossRef
15.
go back to reference Numata Y, Terui T, Okuyama R, Hirasawa N, Sugiura Y, Miyoshi I, Watanabe T, Kuramasu A, Tagami H, Ohtsu H (2006) The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor. J Invest Dermatol 126:1403–1409PubMedCrossRef Numata Y, Terui T, Okuyama R, Hirasawa N, Sugiura Y, Miyoshi I, Watanabe T, Kuramasu A, Tagami H, Ohtsu H (2006) The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor. J Invest Dermatol 126:1403–1409PubMedCrossRef
16.
go back to reference Schmidt SH, Hellström S (1991) Tympanic membrane structure-new views: a comparative study. ORL 53:32–36PubMedCrossRef Schmidt SH, Hellström S (1991) Tympanic membrane structure-new views: a comparative study. ORL 53:32–36PubMedCrossRef
17.
go back to reference Kaftan H, Herzog M, Miehe B, Hosemann W (2006) Topical application of TGF-β1 in acute traumatic tympanic membrane perforations: an experimental study in rats. Wound Rep Reg 14:453–456CrossRef Kaftan H, Herzog M, Miehe B, Hosemann W (2006) Topical application of TGF-β1 in acute traumatic tympanic membrane perforations: an experimental study in rats. Wound Rep Reg 14:453–456CrossRef
18.
go back to reference Kaftan H, Reuther L, Miehe B, Hosemann W, Herzog M (2008) Delay of tympanic membrane wound healing in rats with topical application of a tyrosine kinase inhibitor. Wound Rep Reg 16:364–369CrossRef Kaftan H, Reuther L, Miehe B, Hosemann W, Herzog M (2008) Delay of tympanic membrane wound healing in rats with topical application of a tyrosine kinase inhibitor. Wound Rep Reg 16:364–369CrossRef
19.
go back to reference Fina M, Baird A, Ryan A (1993) Direct application of basic fibroblast growth factor improves tympanic membrane perforation healing. Laryngoscope 103:804–809PubMedCrossRef Fina M, Baird A, Ryan A (1993) Direct application of basic fibroblast growth factor improves tympanic membrane perforation healing. Laryngoscope 103:804–809PubMedCrossRef
20.
go back to reference Lehmann EL (1998) Nonparametrics: Statistical methods based on ranks. New Jersey, Prentice Hall, pp 156–201 Lehmann EL (1998) Nonparametrics: Statistical methods based on ranks. New Jersey, Prentice Hall, pp 156–201
21.
go back to reference Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Rep Reg 16:585–601CrossRef Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Rep Reg 16:585–601CrossRef
22.
go back to reference Mondain M, Renard N, Ryan A (1995) Neutralizing antibodies against basic fibroblast growth factor influence the healing of traumatic tympanic membrane perforations. ORL 57:28–32PubMedCrossRef Mondain M, Renard N, Ryan A (1995) Neutralizing antibodies against basic fibroblast growth factor influence the healing of traumatic tympanic membrane perforations. ORL 57:28–32PubMedCrossRef
23.
go back to reference Powers CJ, McLeskey SW, Wellstein A (2000) Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7:165–197PubMedCrossRef Powers CJ, McLeskey SW, Wellstein A (2000) Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7:165–197PubMedCrossRef
24.
go back to reference Kaftan H, Reuther L, Miehe B, Hosemann W, Herzog M (2010) The influence of inhibition of the epidermal growth factor receptor on tympanic membrane wound healing in rats. Growth Factors 28:286–292PubMedCrossRef Kaftan H, Reuther L, Miehe B, Hosemann W, Herzog M (2010) The influence of inhibition of the epidermal growth factor receptor on tympanic membrane wound healing in rats. Growth Factors 28:286–292PubMedCrossRef
25.
go back to reference Yamanaka H, Obata K, Kobayashi K, Dai Y, Fukuoka T, Noguchi K (2007) Activation of fibroblast growth factor receptor by axotomy, through downstream p38 in dorsal root ganglion, contributes to neuropathic pain. Neuroscience 150:202–211PubMedCrossRef Yamanaka H, Obata K, Kobayashi K, Dai Y, Fukuoka T, Noguchi K (2007) Activation of fibroblast growth factor receptor by axotomy, through downstream p38 in dorsal root ganglion, contributes to neuropathic pain. Neuroscience 150:202–211PubMedCrossRef
26.
go back to reference Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B, Raffestin B, Eddahibi S (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119:512–523PubMedCrossRef Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B, Raffestin B, Eddahibi S (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119:512–523PubMedCrossRef
27.
go back to reference Ramsay HA, Heikkonen EJ, Laurila PK (1995) Effect of epidermal growth factor on tympanic membranes with chronic perforations: a clinical trial. Otolaryngol Head Neck Surg 113:375–379PubMedCrossRef Ramsay HA, Heikkonen EJ, Laurila PK (1995) Effect of epidermal growth factor on tympanic membranes with chronic perforations: a clinical trial. Otolaryngol Head Neck Surg 113:375–379PubMedCrossRef
Metadata
Title
Inhibition of fibroblast growth factor receptor 1: influence on tympanic membrane wound healing in rats
Authors
Holger Kaftan
Lars Reuther
Bärbel Miehe
Werner Hosemann
Achim Beule
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2012
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-011-1627-6

Other articles of this Issue 1/2012

European Archives of Oto-Rhino-Laryngology 1/2012 Go to the issue